MetLife Director Daniel S. Glaser Receives Quarterly Board Equity Retainer
METLIFE INC
Subscribe to track MET
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 4 Alert: METLIFE INC ($MET) Insider: Glaser Daniel S (Director) Type: Acquisition (Award / Retainer Fee) Shares: 544 @ $94.35 ($51,326.40) Ownership After: 3,249 direct shares (+198 indirect via GRAT) Significance: Low (Routine quarterly director compensation)
Comprehensive Analysis
Executive Summary
On October 1, 2026, MetLife, Inc. ($MET) Board Director Daniel S. Glaser acquired 544 shares of common stock at a price of $94.35 per share, representing an aggregate transaction value of approximately $51,326.40. The transaction was reported on Form 4 filed with the SEC on October 5, 2026.
Transaction Details
- Security: MetLife, Inc. Common Stock
- Transaction Code: 'A' (Grant, award, or other acquisition)
- Shares Acquired: 544
- Price per Share: $94.35
- Total Consideration: $51,326.40
- Post-Transaction Direct Ownership: 3,249 shares
- Indirect Ownership: 198 shares held in a Grantor Retained Annuity Trust (GRAT)
Context & Significance
This transaction carries Low informational significance for public market investors. According to the filing footnotes, the acquisition reflects routine compensation under MetLife's non-management director compensation program, which pays a portion of director retainer fees in company common stock. Director Glaser elected to defer receipt of the shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Because this represents standard board remuneration rather than an open-market, discretionary purchase, it does not convey an active directional signal on company performance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
